A fibronectin mimetic motif improves integrin mediated cell biding to recombinant spider silk matrices

Biomaterials

Volumn 74, Issue , 2016, Pages 256-266

  Widhe, Mona ^a   Shalaly, Nancy Dekki ^a   Hedhammar, My ^a,b  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Cell adhesion; Disulphide bridged loop; RGD; Wound healing

Indexed keywords

AMINO ACIDS; BINDING ENERGY; BINS; BIOMIMETICS; CELL ADHESION; CELLS; CYTOLOGY; GENETIC ENGINEERING; LINEAR CONTROL SYSTEMS; TISSUE ENGINEERING;

DISULPHIDE BRIDGED LOOP; FOCAL ADHESIONS; FREESTANDING FILMS; FUTURE APPLICATIONS; LINEAR CONTROLS; MONOLAYER CULTURE; RGD; WOUND HEALING;

CELL ENGINEERING;

ARGINYLGLYCYLASPARTIC ACID; FIBRONECTIN; INTEGRIN; PEPTIDOMIMETIC AGENT; RECOMBINANT SPIDER SILK; SILK; UNCLASSIFIED DRUG; PROTEIN BINDING;

ADHERENT CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CELL VIABILITY; CONTROLLED STUDY; DERMAL MICROVASCULAR ENDOTHELIAL CELL; FOCAL ADHESION; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; KERATINOCYTE; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MOTIF; STRESS FIBER; TISSUE ENGINEERING; ANIMAL; CELL CULTURE; CHEMISTRY; METABOLISM; MOLECULAR MIMICRY; SPIDER;

ANIMALS; CELL ADHESION; CELLS, CULTURED; FIBRONECTINS; HUMANS; INTEGRINS; MOLECULAR MIMICRY; PROTEIN BINDING; SILK; SPIDERS;

EID: 84945162199     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.10.013     Document Type: Article

References (70)

1. Kuhbier J.W., Allmeling C., Reimers K., Hillmer A., Kasper C., Menger B., et al. Interactions between spider silk and cells - NIH/3T3 fibroblasts seeded on miniature weaving frames. PLoS One 2010, 5:e12032.
2. Widhe M., Bysell H., Nystedt S., Schenning I., Malmsten M., Johansson J., et al. Recombinant spider silk as matrices for cell culture. Biomaterials 2010, 31:9575-9585.
3. Widhe M., Johansson U., Hillerdahl C.O., Hedhammar M. Recombinant spider silk with cell binding motifs for specific adherence of cells. Biomaterials 2013, 34:8223-8234.
4. Wohlrab S., Muller S., Schmidt A., Neubauer S., Kessler H., Leal-Egana A., et al. Cell adhesion and proliferation on RGD-modified recombinant spider silk proteins. Biomaterials 2012, 33:6650-6659.
5. Pierschbacher M.D., Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 1984, 309:30-33.
6. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24:4385-4415.
7. Ruoslahti E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 1996, 12:697-715.
8. Koivunen E., Arap W., Rajotte D., Lahdenranta J., Pasqualini R. Identification of receptor ligands with phage display peptide libraries. J. Nucl. Med. 1999, 40:883-888.
9. Johansson S., Svineng G., Wennerberg K., Armulik A., Lohikangas L. Fibronectin-integrin interactions. Front. Biosci. 1997, 2:d126-d146.
10. Ruoslahti E., Pierschbacher M.D. New perspectives in cell adhesion: RGD and integrins. Science 1987, 238:491-497.
11. Pierschbacher M.D., Ruoslahti E. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J. Biol. Chem. 1987, 262:17294-17298.
12. Cheng S., Craig W.S., Mullen D., Tschopp J.F., Dixon D., Pierschbacher M.D. Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists. J. Med. Chem. 1994, 37:1-8.
13. Koivunen E., Wang B., Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnol. (N.Y.) 1995, 13:265-270.
14. Preissner K.T. Structure and biological role of vitronectin. Annu. Rev. Cell Biol. 1991, 7:275-310.
15. Hautanen A., Gailit J., Mann D.M., Ruoslahti E. Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J. Biol. Chem. 1989, 264:1437-1442.
16. Pytela R., Pierschbacher M.D., Ruoslahti E. Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 1985, 40:191-198.
17. Takagi J. Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins. Biochem. Soc. Trans. 2004, 32:403-406.
18. Dickinson C.D., Gay D.A., Parello J., Ruoslahti E., Ely K.R. Crystals of the cell-binding module of fibronectin obtained from a series of recombinant fragments differing in length. J. Mol. Biol. 1994, 238:123-127.
19. Leahy D.J., Aukhil I., Erickson H.P. 2.0 A crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell 1996, 84:155-164.
20. Main A.L., Harvey T.S., Baron M., Boyd J., Campbell I.D. The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions. Cell 1992, 71:671-678.
21. Aota S., Nomizu M., Yamada K.M. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J. Biol. Chem. 1994, 269:24756-24761.
22. Kauf A.C., Hough S.M., Bowditch R.D. Recognition of fibronectin by the platelet integrin alpha IIb beta 3 involves an extended interface with multiple electrostatic interactions. Biochemistry 2001, 40:9159-9166.
23. Redick S.D., Settles D.L., Briscoe G., Erickson H.P. Defining fibronectin's cell adhesion synergy site by site-directed mutagenesis. J. Cell Biol. 2000, 149:521-527.
24. Hedhammar M., Rising A., Grip S., Martinez A.S., Nordling K., Casals C., et al. Structural properties of recombinant nonrepetitive and repetitive parts of major ampullate spidroin 1 from Euprosthenops australis: implications for fiber formation. Biochemistry 2008, 47:3407-3417.
25. Hedhammar M., Bramfeldt H., Baris T., Widhe M., Askarieh G., Nordling K., et al. Sterilized recombinant spider silk fibers of low pyrogenicity. Biomacromolecules 2010, 11:953-959.
26. Mould A.P., Barton S.J., Askari J.A., McEwan P.A., Buckley P.A., Craig S.E., et al. Conformational changes in the integrin beta A domain provide a mechanism for signal transduction via hybrid domain movement. J. Biol. Chem. 2003, 278:17028-17035.
27. Clark K., Pankov R., Travis M.A., Askari J.A., Mould A.P., Craig S.E., et al. A specific alpha5beta1-integrin conformation promotes directional integrin translocation and fibronectin matrix formation. J. Cell Sci. 2005, 118:291-300.
28. Delcommenne M., Streuli C.H. Control of integrin expression by extracellular matrix. J. Biol. Chem. 1995, 270:26794-26801.
29. Kim L.T., Ishihara S., Lee C.C., Akiyama S.K., Yamada K.M., Grinnell F. Altered glycosylation and cell surface expression of beta 1 integrin receptors during keratinocyte activation. J. Cell Sci. 1992, 103(Pt 3):743-753.
30. Witz C.A., Montoya-Rodriguez I.A., Miller D.M., Schneider B.G., Schenken R.S. Mesothelium expression of integrins in vivo and in vitro. J. Soc. Gynecol. Investig. 1998, 5:87-93.
31. Fraioli R., Rechenmacher F., Neubauer S., Manero J.M., Gil J., Kessler H., et al. Mimicking bone extracellular matrix: integrin-binding peptidomimetics enhance osteoblast-like cells adhesion, proliferation, and differentiation on titanium. Colloid. Surf. B Biointerfaces 2015, 128:191-200.
32. Li M.L., Aggeler J., Farson D.A., Hatier C., Hassell J., Bissell M.J. Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:136-140.
33. Westerfield M. Substrate interactions affecting motor growth cone guidance during development and regeneration. J. Exp. Biol. 1987, 132:161-175.
34. Garcia A.J., Vega M.D., Boettiger D. Modulation of cell proliferation and differentiation through substrate-dependent changes in fibronectin conformation. Mol. Biol. Cell 1999, 10:785-798.
35. Pankov R., Yamada K.M. Fibronectin at a glance. J. Cell Sci. 2002, 115:3861-3863.
36. George E.L., Georges-Labouesse E.N., Patel-King R.S., Rayburn H., Hynes R.O. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 1993, 119:1079-1091.
37. Yang J.T., Rayburn H., Hynes R.O. Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 1993, 119:1093-1105.
38. Herard A.L., Pierrot D., Hinnrasky J., Kaplan H., Sheppard D., Puchelle E., et al. Fibronectin and its alpha 5 beta 1-integrin receptor are involved in the wound-repair process of airway epithelium. Am. J. Physiol. 1996, 271:L726-L733.
39. Kim S., Bell K., Mousa S.A., Varner J.A. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 2000, 156:1345-1362.
40. Koivunen E., Gay D.A., Ruoslahti E. Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library. J. Biol. Chem. 1993, 268:20205-20210.
41. Faull R.J., Kovach N.L., Harlan J.M., Ginsberg M.H. Affinity modulation of integrin alpha 5 beta 1: regulation of the functional response by soluble fibronectin. J. Cell Biol. 1993, 121:155-162.
42. Aumailley M., Gurrath M., Muller G., Calvete J., Timpl R., Kessler H. Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett. 1991, 291:50-54.
43. Kantlehner M., Schaffner P., Finsinger D., Meyer J., Jonczyk A., Diefenbach B., et al. Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem 2000, 1:107-114.
44. Marinelli L., Meyer A., Heckmann D., Lavecchia A., Novellino E., Kessler H. Ligand binding analysis for human alpha5beta1 integrin: strategies for designing new alpha5beta1 integrin antagonists. J. Med. Chem. 2005, 48:4204-4207.
45. Heckmann D., Meyer A., Marinelli L., Zahn G., Stragies R., Kessler H. Probing integrin selectivity: rational design of highly active and selective ligands for the alpha5beta1 and alphavbeta3 integrin receptor. Angew. Chem. Int. Ed. Engl. 2007, 46:3571-3574.
46. Stragies R., Osterkamp F., Zischinsky G., Vossmeyer D., Kalkhof H., Reimer U., et al. Design and synthesis of a new class of selective integrin alpha5beta1 antagonists. J. Med. Chem. 2007, 50:3786-3794.
47. Liddington R.C. Structural aspects of integrins. Adv. Exp. Med. Biol. 2014, 819:111-126.
48. Rechenmacher F., Neubauer S., Polleux J., Mas-Moruno C., De Simone M., Cavalcanti-Adam E.A., et al. Functionalizing alphavbeta3- or alpha5beta1-selective integrin antagonists for surface coating: a method to discriminate integrin subtypes in vitro. Angew. Chem. Int. Ed. Engl. 2013, 52:1572-1575.
49. Asakura T., Nishi H., Nagano A., Yoshida A., Nakazawa Y., Kamiya M., et al. NMR analysis of the fibronectin cell-adhesive sequence, Arg-Gly-Asp, in a recombinant silk-like protein and a model peptide. Biomacromolecules 2011, 12:3910-3916.
50. Maeda T., Hashino K., Oyama R., Titani K., Sekiguchi K. Artificial cell adhesive proteins engineered by grafting the Arg-Gly-Asp cell recognition signal: factors modulating the cell adhesive activity of the grafted signal. J. Biochem. 1991, 110:381-387.
51. Silverman A.P., Levin A.M., Lahti J.L., Cochran J.R. Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities. J. Mol. Biol. 2009, 385:1064-1075.
52. Li J., Ji J., Holmes L.M., Burgin K.E., Barton L.B., Yu X., et al. Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor. Cancer Gene Ther. 2004, 11:363-370.
53. Krezel A.M., Wagner G., Seymour-Ulmer J., Lazarus R.A. Structure of the RGD protein decorsin: conserved motif and distinct function in leech proteins that affect blood clotting. Science 1994, 264:1944-1947.
54. Leahy D.J., Hendrickson W.A., Aukhil I., Erickson H.P. Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein. Science 1992, 258:987-991.
55. Mayasundari A., Whittemore N.A., Serpersu E.H., Peterson C.B. The solution structure of the N-terminal domain of human vitronectin: proximal sites that regulate fibrinolysis and cell migration. J. Biol. Chem. 2004, 279:29359-29366.
56. Widhe M., Johansson J., Hedhammar M., Rising A. Invited review current progress and limitations of spider silk for biomedical applications. Biopolymers 2012, 97:468-478.
57. Bini E., Foo C.W., Huang J., Karageorgiou V., Kitchel B., Kaplan D.L. RGD-functionalized bioengineered spider dragline silk biomaterial. Biomacromolecules 2006, 7:3139-3145.
58. Hofmann S., Stok K.S., Kohler T., Meinel A.J., Muller R. Effect of sterilization on structural and material properties of 3-D silk fibroin scaffolds. Acta biomater. 2014, 10:308-317.
59. Wang H., Ma L., Yang S., Shao Z., Meng C., Duan D., et al. Effect of RGD-modified silk material on the adhesion and proliferation of bone marrow-derived mesenchymal stem cells. J. Huazhong Univ. Sci. Technol. Med. Sci.=Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban=Huazhong keji daxue xuebao Yixue Yingdewen ban 2009, 29:80-83.
60. Morgan A.W., Roskov K.E., Lin-Gibson S., Kaplan D.L., Becker M.L., Simon C.G. Characterization and optimization of RGD-containing silk blends to support osteoblastic differentiation. Biomaterials 2008, 29:2556-2563.
61. Zhao J., Qiu H., Chen D.L., Zhang W.X., Zhang D.C., Li M. Development of nanofibrous scaffolds for vascular tissue engineering. Int. J. Biol. Macromol. 2013, 56:106-113.
62. Chollet C., Chanseau C., Remy M., Guignandon A., Bareille R., Labrugere C., et al. The effect of RGD density on osteoblast and endothelial cell behavior on RGD-grafted polyethylene terephthalate surfaces. Biomaterials 2009, 30:711-720.
63. Massia S.P., Hubbell J.A. An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. J. Cell Biol. 1991, 114:1089-1100.
64. Orgovan N., Peter B., Bosze S., Ramsden J.J., Szabo B., Horvath R. Dependence of cancer cell adhesion kinetics on integrin ligand surface density measured by a high-throughput label-free resonant waveguide grating biosensor. Sci. Rep. 2014, 4:4034.
65. Xiao Y., Truskey G.A. Effect of receptor-ligand affinity on the strength of endothelial cell adhesion. Biophys. J. 1996, 71:2869-2884.
66. Dhall S., Do D., Garcia M., Wijesinghe D.S., Brandon A., Kim J., et al. A novel model of chronic wounds: importance of redox imbalance and biofilm-forming bacteria for establishment of chronicity. PLoS One 2014, 9:e109848.
67. Misic A.M., Gardner S.E., Grice E.A. The wound microbiome: modern approaches to examining the role of microorganisms in impaired chronic wound healing. Adv. Wound Care 2014, 3:502-510.
68. Siddiqui A.R., Bernstein J.M. Chronic wound infection: facts and controversies. Clin. Dermatol. 2010, 28:519-526.
69. Mithieux S.M., Wise S.G., Weiss A.S. Tropoelastin - a multifaceted naturally smart material. Adv. Drug Deliv. Rev. 2013, 65:421-428.
70. Van Belle E., Tio F.O., Couffinhal T., Maillard L., Passeri J., Isner J.M. Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation 1997, 95:438-448.